Rasagiline-str-1 (Rasagiline Str 1)
Rasagiline Tablet
Product Images NDC 67877-259
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 67877-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rasagiline-tab-0.5mg-30s (Rasagiline Tab 0.5mg 30s)
Each tablet contains rasagiline mesylate equivalent to 0.5mg rasagiline. The tablets are manufactured by Akem Laboratories Ltd, located in Mumbai, India, and distributed by Ascend Laboratories in Parsippany, NJ. Dosage information is available in the accompanying prescribing information. The tablets should be stored at 25°C (77°F) with excursions permitted up to controlled room temperature. The batch number is DDI230, and the product is identified by the NDC number 67877-259-30. There is a UV varnish on the rest label.*
Rasagiline-tab-1mg-30s (Rasagiline Tab 1mg 30s)
Each tablet contains rasagiline mesylate equivalent to 1 mg rasagiline. Store at 25°C (77°F); excursions permitted to 15°1030°C (59° 0 86°F). Dosage information is not available. The product is manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories. The product label indicates it is Rasagiline tablets, and there are 30 tablets in a package. The rest of the text is related to production and labeling information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
